Description

Composition: CJC-1295 10 mg • Ipamorelin 10 mg

Description:
The CJC-1295 + Ipamorelin Blend is a dual-peptide formulation designed for advanced research on growth-hormone–releasing mechanisms and endocrine regulation. Both peptides act through complementary pathways to stimulate endogenous GH secretion in controlled laboratory environments—CJC-1295 as a growth hormone–releasing hormone (GHRH) analog, and Ipamorelin as a selective ghrelin receptor agonist (GHSR). Their combined use offers a valuable model for exploring synergistic signaling cascades related to cellular growth, metabolism, and pituitary modulation.

Research Applications:
This blend is widely utilized in preclinical and in vitro research examining:

• Synergistic GHRH and ghrelin receptor pathway activation
• Mechanistic studies of GH release and endocrine regulation
• Cellular signaling and receptor binding kinetics
• Investigations of metabolic and anabolic peptide interactions

Component Details:

• CJC-1295 (GHRH Analog) – 10 mg
  • Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Gln-Lys-NH₂
  • Molecular Formula: C₁₅₂H₂₅₂N₄₄O₂₉
  • Molecular Weight: ≈ 3367.9 g/mol
• Ipamorelin (Ghrelin Receptor Agonist) – 10 mg
  • Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
  • Molecular Formula: C₃₈H₄₉N₉O₅
  • Molecular Weight: 711.85 g/mol

Form: Lyophilized powder
Purity: ≥ 98 % (HPLC)
Storage: Store at –20 °C. Avoid repeated freeze-thaw cycles.
Solubility: Soluble in sterile water or aqueous buffer

Handling and Use:
This material is intended strictly for in vitro laboratory research. It is not for human consumption, veterinary use, or diagnostic purposes. All handling should follow appropriate laboratory safety and aseptic procedures.